New Risk • Jun 02
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩149.1b (US$98.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.8% net profit margin). Market cap is less than US$100m (₩149.1b market cap, or US$98.2m). Announcement • Mar 06
Iljin Diamond Co.,Ltd, Annual General Meeting, Mar 19, 2026 Iljin Diamond Co.,Ltd, Annual General Meeting, Mar 19, 2026, at 09:00 Tokyo Standard Time. Location: conference room, 157, daegeum-ro, daeso-myeon, eumseong-gun, chungcheongbuk-do, South Korea Buy Or Sell Opportunity • Mar 04
Now 24% undervalued Over the last 90 days, the stock has risen 4.2% to ₩13,030. The fair value is estimated to be ₩17,153, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.5% over the last 3 years. Earnings per share has grown by 67%. Valuation Update With 7 Day Price Move • Feb 19
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩16,240, the stock trades at a trailing P/E ratio of 21.2x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 9.4% over the past three years. Buy Or Sell Opportunity • Jan 30
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 4.9% to ₩13,300. The fair value is estimated to be ₩16,651, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.5% over the last 3 years. Earnings per share has grown by 67%. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩13,660, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 24% over the past three years. Reported Earnings • Nov 19
Third quarter 2025 earnings released: EPS: ₩85.00 (vs ₩79.00 in 3Q 2024) Third quarter 2025 results: EPS: ₩85.00 (up from ₩79.00 in 3Q 2024). Revenue: ₩48.6b (up 18% from 3Q 2024). Net income: ₩1.21b (up 8.1% from 3Q 2024). Profit margin: 2.5% (down from 2.7% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. New Risk • Oct 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Oct 13
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₩14,250, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 2.5% over the past three years. Reported Earnings • Aug 16
Second quarter 2025 earnings released: EPS: ₩195 (vs ₩229 in 2Q 2024) Second quarter 2025 results: EPS: ₩195 (down from ₩229 in 2Q 2024). Revenue: ₩38.0b (down 8.0% from 2Q 2024). Net income: ₩2.77b (down 15% from 2Q 2024). Profit margin: 7.3% (down from 7.9% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Aug 01
Now 22% undervalued The stock has been flat over the last 90 days, currently trading at ₩12,100. The fair value is estimated to be ₩15,510, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has grown by 40%. Buy Or Sell Opportunity • May 22
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 5.2% to ₩12,040. The fair value is estimated to be ₩15,187, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has grown by 40%. Reported Earnings • Mar 14
Full year 2024 earnings released: EPS: ₩908 (vs ₩716 in FY 2023) Full year 2024 results: EPS: ₩908 (up from ₩716 in FY 2023). Revenue: ₩157.1b (up 1.7% from FY 2023). Net income: ₩12.9b (up 27% from FY 2023). Profit margin: 8.2% (up from 6.6% in FY 2023). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings. Announcement • Mar 06
Iljin Diamond Co.,Ltd, Annual General Meeting, Mar 20, 2025 Iljin Diamond Co.,Ltd, Annual General Meeting, Mar 20, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 157, daegeum-ro, daeso-myeon, eumseong-gun, chungcheongbuk-do, South Korea New Risk • Dec 09
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩137.7b (US$96.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₩137.7b market cap, or US$96.1m). New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Aug 15
Second quarter 2024 earnings released: EPS: ₩229 (vs ₩168 in 2Q 2023) Second quarter 2024 results: EPS: ₩229 (up from ₩168 in 2Q 2023). Revenue: ₩41.3b (up 16% from 2Q 2023). Net income: ₩3.25b (up 36% from 2Q 2023). Profit margin: 7.9% (up from 6.7% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings. New Risk • May 23
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 32% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.3% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • May 02
Investor sentiment improves as stock rises 40% After last week's 40% share price gain to ₩18,020, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total loss to shareholders of 54% over the past three years. Reported Earnings • Mar 15
Full year 2023 earnings released: EPS: ₩716 (vs ₩464 loss in FY 2022) Full year 2023 results: EPS: ₩716 (up from ₩464 loss in FY 2022). Revenue: ₩154.5b (down 17% from FY 2022). Net income: ₩10.2b (up ₩16.7b from FY 2022). Profit margin: 6.6% (up from net loss in FY 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Dec 20
Upcoming dividend of ₩300 per share at 2.1% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 17 April 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.1%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%). Reported Earnings • Nov 17
Third quarter 2023 earnings released: EPS: ₩166 (vs ₩142 in 3Q 2022) Third quarter 2023 results: EPS: ₩166 (up from ₩142 in 3Q 2022). Revenue: ₩39.0b (down 18% from 3Q 2022). Net income: ₩2.36b (up 17% from 3Q 2022). Profit margin: 6.0% (up from 4.3% in 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 34 percentage points per year, which is a significant difference in performance. Reported Earnings • Mar 17
Full year 2022 earnings released: ₩463 loss per share (vs ₩607 profit in FY 2021) Full year 2022 results: ₩463 loss per share (down from ₩607 profit in FY 2021). Revenue: ₩186.8b (flat on FY 2021). Net loss: ₩6.58b (down 176% from profit in FY 2021). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Upcoming Dividend • Dec 21
Upcoming dividend of ₩400 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 20 April 2023. Payout ratio is on the higher end at 96% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.3%). In line with average of industry peers (2.4%). Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩16,350, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 15x in the Machinery industry in South Korea. Total loss to shareholders of 46% over the past three years. Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₩20,500, the stock trades at a trailing P/E ratio of 29.7x. Average trailing P/E is 19x in the Machinery industry in South Korea. Total loss to shareholders of 28% over the past three years. Reported Earnings • May 19
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2022 results: EPS: ₩139 (up from ₩56.28 in 1Q 2021). Revenue: ₩33.2b (down 5.2% from 1Q 2021). Net income: ₩2.00b (up 143% from 1Q 2021). Profit margin: 6.0% (up from 2.4% in 1Q 2021). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 21%. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩23,500, the stock trades at a trailing P/E ratio of 47.9x. Average trailing P/E is 16x in the Machinery industry in South Korea. Total loss to shareholders of 38% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩300 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 18 April 2022. Payout ratio is a comfortable 61% but the company is not cash flow positive. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (2.8%). Reported Earnings • May 19
First quarter 2021 earnings released: EPS ₩58.36 (vs ₩228 in 1Q 2020) The company reported a poor first quarter result with weaker earnings and profit margins, although revenues were flat. First quarter 2021 results: Revenue: ₩35.1b (flat on 1Q 2020). Net income: ₩824.3m (down 75% from 1Q 2020). Profit margin: 2.4% (down from 9.2% in 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings. Announcement • Mar 12
Iljin Diamond Co. Ltd., Annual General Meeting, Mar 26, 2021 Iljin Diamond Co. Ltd., Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time. Is New 90 Day High Low • Feb 26
New 90-day low: ₩44,350 The company is down 15% from its price of ₩52,300 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 4.0% over the same period. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩300 Per Share Will be paid on the 8th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.6% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (2.8%). Is New 90 Day High Low • Oct 19
New 90-day low: ₩49,200 The company is down 17% from its price of ₩59,300 on 21 July 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 1.0% over the same period.